ProShare Advisors’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,694
| Closed | -$929K | – | 1827 |
|
|
2019
Q3 | $929K | Buy |
13,694
+652
| +5% | +$44.8K | 0.01% | 764 |
|
|
2019
Q2 | $759K | Sell |
13,042
-1,774
| -12% | -$105K | ﹤0.01% | 863 |
|
|
2019
Q1 | $1.04M | Buy |
14,816
+365
| +3% | +$27.1K | 0.01% | 744 |
|
|
2018
Q4 | $931K | Sell |
14,451
-2,732
| -16% | -$192K | 0.01% | 729 |
|
|
2018
Q3 | $1.21M | Sell |
17,183
-413
| -2% | -$24.2K | 0.01% | 749 |
|
|
2018
Q2 | $887K | Sell |
17,596
-1,045
| -6% | -$41.5K | 0.01% | 880 |
|
|
2018
Q1 | $583K | Sell |
18,641
-3,033
| -14% | -$101K | ﹤0.01% | 1041 |
|
|
2017
Q4 | $741K | Buy |
21,674
+803
| +4% | +$25.6K | 0.01% | 958 |
|
|
2017
Q3 | $670K | Buy |
20,871
+1,500
| +8% | +$47.3K | 0.01% | 852 |
|
|
2017
Q2 | $631K | Sell |
19,371
-649
| -3% | -$20.6K | 0.01% | 877 |
|
|
2017
Q1 | $630K | Sell |
20,020
-5,098
| -20% | -$151K | 0.01% | 929 |
|
|
2016
Q4 | $738K | Buy |
25,118
+2,235
| +10% | +$68.1K | 0.01% | 909 |
|
|
2016
Q3 | $662K | Sell |
22,883
-3,975
| -15% | -$111K | 0.01% | 831 |
|
|
2016
Q2 | $695K | Buy |
26,858
+591
| +2% | +$15.7K | 0.01% | 838 |
|
|
2016
Q1 | $651K | Sell |
26,267
-2,492
| -9% | -$68.4K | 0.01% | 885 |
|
|
2015
Q4 | $1.01M | Buy |
28,759
+2,287
| +9% | +$61.3K | 0.01% | 730 |
|
|
2015
Q3 | $560K | Sell |
26,472
-1,551
| -6% | -$40K | 0.01% | 900 |
|
|
2015
Q2 | $779K | Sell |
28,023
-761
| -3% | -$21.5K | 0.01% | 890 |
|
|
2015
Q1 | $879K | Buy |
28,784
+4,193
| +17% | +$133K | 0.01% | 910 |
|
|
2014
Q4 | $786K | Buy |
24,591
+1,714
| +7% | +$55.8K | 0.01% | 973 |
|
|
2014
Q3 | $648K | Sell |
22,877
-4,221
| -16% | -$118K | 0.01% | 1250 |
|
|
2014
Q2 | $742K | Sell |
27,098
-13,382
| -33% | -$356K | 0.01% | 1327 |
|
|
2014
Q1 | $1.07M | Buy |
40,480
+25,755
| +175% | +$739K | 0.01% | 1262 |
|
|
2013
Q4 | $431K | Sell |
14,725
-6,597
| -31% | -$209K | 0.01% | 1087 |
|
|
2013
Q3 | $652K | Buy |
21,322
+5,117
| +32% | +$171K | 0.02% | 1225 |
|
|
2013
Q2 | $514K | Buy |
+16,205
| New | +$532K | 0.01% | 1316 |
|
ProShare Advisors's GHDX Position: Q4 2019 in Review
ProShare Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 13,694 shares — an estimated $929K sold.
ProShare Advisors first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $1.21M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- ProShare Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- ProShare Advisors sold 13,694 Genomic Health, Inc. shares in Q4 2019, an estimated $929K.
- ProShare Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- ProShare Advisors's Genomic Health, Inc. position peaked at $1.21M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.